Bayer and Bristol's rival clot drugs both impress
August 31, 2010 at 11:59 AM EDT
STOCKHOLM (Reuters) - Rival anti-clotting drugs from Bayer and Bristol-Myers Squibb both impressed in clinical trials, keeping them firmly in the race to displace the old, problematic heart drug warfarin.
